Indiana hospitals are racking up millions of dollars in penalties for having too many patients return for care within a month of discharge.
Since starting a wellness program in 2010, IndyGo has seen employee participation climb from just a few, skeptical workers to 97 percent of the workforce.
As a candidate, President Trump advocated Medicare negotiations and allowing consumers to import medicines from abroad. His current strategy recommends changes to policies that the administration believes unwittingly lead to higher prices, and suggests ways to speed drugs to market and increase competition.
Lawmakers stripped a provision from the bill that would have boosted the cigarette tax from 99 cents a pack to $2.99.
Indianapolis-based Springbuk expects to grow by leaps and bounds after landing a big package of venture capital.
Alex Azar, a former Eli Lilly and Co. executive, acknowledged to the Senate Finance Committee that drug prices are too high and said he'd work to lower them if confirmed as secretary of Health and Human Services.
The National Business Group on Health is projecting the total cost of providing medical and pharmacy benefits to increase 5 percent for the fifth consecutive year in 2018.
Without dozens of insurance claims to file and follow up, physicians cut administrative overhead, reduce costs and keep their practices limited to a few hundred patients, rather than a few thousand.
The state is asking vendors to submit bid packages by June 12 for a drug whose price has spiked in recent years.
In Lilly’s partnership with Harvard Pilgrim Health Care, the not-for-profit insurer gets additional rebates if fewer patients using Lilly's diabetes treatment Trulicity meet blood sugar goals than expected.
Indiana now has one of the lowest cigarette taxes in the nation. It also has one of the highest smoking rates. Some groups want to decrease the latter in part by raising the former.
President-elect Donald Trump promised to drive down the cost of medicines, defying investors who saw a boon in his election last month and injecting himself again into a contentious economic debate.
For patients, the difference between getting an operation now or in January could amount to thousands of dollars out of pocket.
Pharma giant Novo Nordisk announced Thursday that it is cutting 1,000 jobs after slashing forecasts for 2016, citing lower prices for diabetes drugs. Novo and competitors such as Indianapolis-based Eli Lilly will likely have to keep tightening their belts as prices and profit margins fall, experts say.